Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15
The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
An old cancer drug's degrading new look: Typically, cancer drugs that help only a small number of patients in clinical trials are not pursued. This might change in a future world of precision medicine, where biomarkers will match specific drugs to the patients most likely to respond. Han et al. identified the mechanism of action of a cancer drug called indisulam, a sulfonamide tested previously in patients with solid tumors. Indisulam and related sulfonamides killed cells by disrupting precursor mRNA splicing. The drugs targeted a specific RNA splicing factor for degradation by “gluing” it to the CUL4-DCAF15 ubiquitin ligase. Experiments with cancer cell lines suggest that future clinical trials of these drugs should focus on leukemias and lymphomas with high DCAF15 expression levels. Science , this issue p. eaal3755
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, aryl sulphonamides degrade the essential RNA-binding protein RBM39 by engaging DCAF15, the substrate receptor of the CRL4DCAF15 E3 ubiquitin ligase13–15.”
From The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K (2020) · cites this paper as [13]
In the citing paper
“it took two decades to determine that indisulam, and the related sulfonamides e7820 and chloroquinoxaline sulfonamide (cQS), were in fact glue degraders that targeted the splicing factor RBM39 (Han et al. 2017;uehara et al. 2017).”
From From serendipity to strategy: molecular glue degraders in cancer therapeutics (2025) · cites this paper as Han et al. 2017
In the citing paper
“indisulam facilitated an interaction between RBM39 and DcAF15, a substrate receptor component of the cRl4 DcAF15 ligase complex (Han et al. 2017;uehara et al. 2017).”
From From serendipity to strategy: molecular glue degraders in cancer therapeutics (2025) · cites this paper as Han et al. 2017
In the citing paper
“However, sulfonamides such as indisulam and similar SPlAMs were serendipitously discovered to degrade RBM39 by stabilizing its native interaction with cRl4 DcAF15 (Han et al. 2017; uehara et al. 2017) (Figure 4A).”
From From serendipity to strategy: molecular glue degraders in cancer therapeutics (2025) · cites this paper as Han et al. 2017
In the citing paper
“The same MG mechanism has subsequently been revealed for antitumor aryl-sulfonamides, which reprograms another CRL4 substrate receptor, DCAF15, to bind and degrade certain RNA-binding proteins21–26.”
From Defining molecular glues with a dual-nanobody cannabidiol sensor (2022) · cites this paper as [21]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668 · cited 1×
“8) (52) to human reference genome (hg19) along with the gene annotation data downloaded from Illumina’s iGenomes (http://support.”
MethodMass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Shevchenko, A., Wilm, M., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,995
Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484 · cited 2×
“As peptides eluted they were subjected to electrospray ionization and then entered into an LTQ Orbitrap Velos Pro ion-trap mass spectrometer (Thermo Fisher Scientific, Waltham, MA).”
MethodNGS QC Toolkit: A Toolkit for Quality Control of Next Generation Sequencing Data
Patel, R. K., & Jain, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030619 · Cited by 2,917
Function and regulation of cullin–RING ubiquitin ligases
Petroski, M. D., & Deshaies, R. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1547 · Cited by 2,148
Identification of a Primary Target of Thalidomide Teratogenicity
Ito, T., Ando, H., Suzuki, T., Ogura, T., Hotta, K., Imamura, Y., Yamaguchi, Y., & Handa, H. (2010) · Science · doi:10.1126/science.1177319 · Cited by 2,136
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Soucy, T. A., Smith, P. G., Milhollen, M. A., Berger, A. J., Gavin, J. M., Adhikari, S., Brownell, J. E., Burke, K. E., Cardin, D. P., Critchley, S., et al. (2009) · Nature · doi:10.1038/nature07884 · Cited by 1,990 · cited 7×
“In many cases, ubiquitin is added to substrates by cullinRING ligases (CRLs), which are multisubunit ubiquitin ligases (23).”
BackgroundInfluentialLenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Krönke, J., Udeshi, N. D., Narla, A., Grauman, P., Hurst, S. N., McConkey, M., Svinkina, T., Heckl, D., Comer, E., Li, X., et al. (2014) · Science · doi:10.1126/science.1244851 · Cited by 1,879
Mechanism of auxin perception by the TIR1 ubiquitin ligase
Tan, X., Calderon-Villalobos, L. I. A., Sharon, M., Zheng, C., Robinson, C. V., Estelle, M., & Zheng, N. (2007) · Nature · doi:10.1038/nature05731 · Cited by 1,688 · cited 1×
“This is the same mechanism by which the plant hormone auxin acts like “molecular glue” to enhance an interaction between the E3 ubiquitin ligase receptor TIR1 and its substrates (43).”
Background
Cited by
Items 701–786 of 786
Dai, X., Cai, L., Zhang, Z., & Li, J. (2023) · Figshare · doi:10.6084/m9.figshare.22697222
Dai, X., Cai, L., Zhang, Z., & Li, J. (2023) · Figshare · doi:10.6084/m9.figshare.22697243
Ji, T., Yang, Y., Yu, J., Yin, H., Chu, X., Yang, P., Xu, L., Wang, X., Hu, S., Li, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26753044
Dai, X., Cai, L., Zhang, Z., & Li, J. (2023) · Figshare · doi:10.6084/m9.figshare.22697231
Ji, T., Yang, Y., Yu, J., Yin, H., Chu, X., Yang, P., Xu, L., Wang, X., Hu, S., Li, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26753068
Ji, T., Yang, Y., Yu, J., Yin, H., Chu, X., Yang, P., Xu, L., Wang, X., Hu, S., Li, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26753029
Dai, X., Cai, L., Zhang, Z., & Li, J. (2023) · Figshare · doi:10.6084/m9.figshare.22697225
Ji, T., Yang, Y., Yu, J., Yin, H., Chu, X., Yang, P., Xu, L., Wang, X., Hu, S., Li, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26753050
Ji, T., Yang, Y., Yu, J., Yin, H., Chu, X., Yang, P., Xu, L., Wang, X., Hu, S., Li, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26753077
Dai, X., Cai, L., Zhang, Z., & Li, J. (2023) · Figshare · doi:10.6084/m9.figshare.22697228
Dai, X., Cai, L., Zhang, Z., & Li, J. (2023) · Figshare · doi:10.6084/m9.figshare.22697246
Dai, X., Cai, L., Zhang, Z., & Li, J. (2023) · Figshare · doi:10.6084/m9.figshare.22697234
Ji, T., Yang, Y., Yu, J., Yin, H., Chu, X., Yang, P., Xu, L., Wang, X., Hu, S., Li, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26753086
Ji, T., Yang, Y., Yu, J., Yin, H., Chu, X., Yang, P., Xu, L., Wang, X., Hu, S., Li, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26753026
Ji, T., Yang, Y., Yu, J., Yin, H., Chu, X., Yang, P., Xu, L., Wang, X., Hu, S., Li, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26753071
Ji, T., Yang, Y., Yu, J., Yin, H., Chu, X., Yang, P., Xu, L., Wang, X., Hu, S., Li, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26753080
Ji, T., Yang, Y., Yu, J., Yin, H., Chu, X., Yang, P., Xu, L., Wang, X., Hu, S., Li, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26753062
Ji, T., Yang, Y., Yu, J., Yin, H., Chu, X., Yang, P., Xu, L., Wang, X., Hu, S., Li, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26753065
Dai, X., Cai, L., Zhang, Z., & Li, J. (2023) · Figshare · doi:10.6084/m9.figshare.22697237
Dai, X., Cai, L., Zhang, Z., & Li, J. (2023) · Figshare · doi:10.6084/m9.figshare.22697213
Ji, T., Yang, Y., Yu, J., Yin, H., Chu, X., Yang, P., Xu, L., Wang, X., Hu, S., Li, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26753083
Ji, T., Yang, Y., Yu, J., Yin, H., Chu, X., Yang, P., Xu, L., Wang, X., Hu, S., Li, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26753095
Ji, T., Yang, Y., Yu, J., Yin, H., Chu, X., Yang, P., Xu, L., Wang, X., Hu, S., Li, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26753035
Schirok, H., Lehmann, L., Torianyk, H., Kary, N., Louloupi, A., Nutiu, R., Yu, Y., & Morais, P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00056-x · Cited by 1
Mass spectrometric analysis of small-molecule-induced ubiquitination and deubiquitination
Führer, S. (2025) · Technische Universität Dortmund Eldorado (Technische Universität Dortmund) · doi:10.17877/de290r-26440
An Integrative Computational Biophysical Workflow for Molecular Glue Discovery
Wang, M., Muhammad, D., Xia, W., Leng, J., Lei, Z., Sun, Z., & Zhang, J. Z. H. (2026) · Journal of Computational Biophysics and Chemistry · doi:10.1142/s2737416526500547
RNA‐Binding Proteins and Ferroptosis in Cancer: Mechanism and Therapeutic Implications
Chang, L., Lu, B., Shang, H., Ding, W., Wei, C., Qi, X., & He, P. (2026) · MedComm – Oncology · doi:10.1002/mog2.70053
Kodadek, T. J. (2026) · Nature Chemical Biology · doi:10.1038/s41589-025-02133-6
Dual Target E3 Ligase Ligands: A New Way to Overcome Drug Resistance
潘, 相. (2026) · Hans Journal of Medicinal Chemistry · doi:10.12677/hjmce.2026.141006
Ma, L., Sheng, X., Wang, L., Wan, X., Chen, R., Li, X., Zheng, R., Xu, L., Zha, X., & Wang, J. (2026) · Oncogene · doi:10.1038/s41388-026-03694-z
Scalable insect cell expression and purification screening applied to CRL4-DCAF substrate receptors
(2026) · doi:10.1016/j.pep.2026.106907
Molecular Glue Degraders Redefining Targeted Therapies From Discovery to Therapeutic Applications
Wen, J., Yu, J., Wen, W., & Jiang, B. (2026) · MedComm – Oncology · doi:10.1002/mog2.70058
Cancer biology and the principles of targeted cancer drug discovery
Davies, A., Jones, G., Krishnan, S., Krishnamoorthy, M., Maruggi, M., Kaneda, M., & Marjon, K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00035-2
Halofuginone is a Molecular Glue Degrader of Integrin β 4
Gong, W., Yang, D., Tian, J., Chai, Y., Yu, T., Wu, Q., Wang, Y., Zhang, W., & Zhan, Q. (2026) · Advanced Science · doi:10.1002/advs.202515970
Yamanaka, S., Nagaoka, K., Shoya, Y., Nishino, K., Mikura, Y., Tanaka, K., Konishi, K., Hasegawa, Y., Hijikata, A., Kosako, H., et al. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.03.004 · Cited by 1
Abbouchi, A. E. (2020) · theses.fr (ABES) · doi:10.70675/35ab1f66z4ca6z4362z97eczbbd1b0a261ee
Discovery and Structural Optimization of BRD4-Selective Monovalent Direct Degraders
Leriche, G., Barmare, F., Toth, J., Jamborcic, A., Kampert, T., Steadman, K., Yang, L., Fish, S., Daniele, E., McCarrick, M., et al. (2026) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6c00022 · Cited by 1
Rôle des mutations de SF3B1 et SUGP1 dans l'épissage aberrant des cancers humains
Canbezdi, C. (2024) · theses.fr (ABES) · doi:10.70675/9503cfbczeb52z4ea5zbc0fzffbe82ec5c03
Kira, K. (2026) · Folia Pharmacologica Japonica · doi:10.1254/fpj.25095
Cao, X., Huang, X., Song, C., Shi, S., Zhu, Y., Zheng, L., Liang, G., & Chen, L. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119034
The emerging roles of alternative splicing in modulating tumor immune responses and immunotherapies
He, X., Zhao, D., Zhou, Y., Jiang, Y., Dong, Z., & Liu, K. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01792-9
Nguyen, A.-H., Li, V., Chen, W., Kimberg, J., Davis, A. J., McFadden, D. G., & Povedano, J. M. (2026) · ACS Chemical Biology · doi:10.1021/acschembio.6c00605
Sulfur(IV)-Mediated Modular Synthesis of γ-Aryl-β-Amino- α,β -Unsaturated Carbonyl Compounds
Lü, W., Zhang, Z., & Ma, C. (2026) · Organic Letters · doi:10.1021/acs.orglett.6c02523
Hu, L., Wang, X., Fan, B., Zhao, Q., Zhong, Y., Lu, Y., Liao, M., Li, H., Fu, X., Wang, H., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.07.019
Serine Starvation Modulates mRNA Splicing through Translational Inhibition of SRSF Proteins
Burns, P. A., Tabatabaei, N., Selfors, L. M., Zhao, H., Sultonova, M., Rawat, V., Paulo, J. A., Sarpey, G. K., Vashi, A., Dahunsi, D. O., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-4971
Xue, Y., Ali, S., Chen, H., & Zhou, J. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01988 · Cited by 1
Dong, J., Li, B., Fu, C., & Kodadek, T. J. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c07205
Panzeri, V., Pieraccioli, M., Ruta, V., Manno, M. V., Caggiano, C., Hartem, D., Riente, A., Milletti, G., Quero, G., Alfieri, S., et al. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-026-03795-3
Cai, D., Li, C., Idrissou, M. B., Hawkins, N. J., Mudududdla, R., Chen, X., Nguyen, T. T., Li, X., Hernandez, R., & Tang, W. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.08.008
Liu, L., Voulgaris, O., Wang, C., Gannon, D., Ritchie, M. E., Feltham, R., & Vervoort, S. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.14.744749
Muñoz-Lasso, D. C., Ni, Y., Weber, G., Eduati, F., Beijersbergen, R. L., Ottmann, C., & Brunsveld, L. (2026) · ACS Chemical Biology · doi:10.1021/acschembio.6c00482
Joo, K. S., Kwon, I. A., Park, J.-Y., & Khang, D. (2026) · Materials Today Nano · doi:10.1016/j.mtnano.2026.100941
Chemically Induced Proximity in Biological Modulation
Jin, X., Zhou, C., & Zhang, X. (2026) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.6c00121
Molecular Glue Degraders in Early Development for Cancer Therapy
Özdemir, E. S., Jang, H., Keskin, O., Gürsoy, A., & Nussinov, R. (2026) · Medicinal Research Reviews · doi:10.1002/med.70104 · Cited by 1
郑, 一. (2026) · Journal of Organic Chemistry Research · doi:10.12677/jocr.2026.143033
A scalable, high-throughput glue perturbation screening platform for molecular glue discovery
Huang, D., Shuang, Z., Chen, L., Ouyang, H., Yang, P., Huang, L., Lu, W., Shi, M., Ding, X., Jiang, B., et al. (2026) · iScience · doi:10.1016/j.isci.2026.117600
The splicing axis of aging: mechanisms and therapeutic opportunities
Raza, S., Kumari, A., & Cieśla, M. (2026) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2026.09.001
Li, J., Liu, S., Fu, L., Bo, Q., Bai, Y., & Dai, X. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1960932
Stańczak, M., & Niazi, S. K. (2026) · Pharmaceuticals · doi:10.3390/ph19101578
Innovation-driven drug discovery: Frontier exploration and breakthrough
Du, S., Hu, X., Clercq, E. D., Liu, X., & Zhan, P. (2026) · The Innovation Medicine · doi:10.59717/j.xinn-med.2026.100262
The ternary complex structure as a foundation for structure-guided molecular glue design
Cowan, A. D. (2026) · Essays in Biochemistry · doi:10.1042/ebc20260026
Wang, T., Ji, C., & Zhao, T. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1967704
Bian, Y., Gao, Y., 常馨, Tian, B., Meng, Q., Xin, L., Lin, H., Wang, W., Li, Z., & Wang, L. (2026) · Cell Discovery · doi:10.1038/s41421-026-00927-z
Ye, Z., Mou, J., Su, H., Luo, J., Cheng, Y., Liu, K., Yang, Z., Qian, D., Tang, H., Xu, M., et al. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168507
BindingDB Entry 50011291: Monomeric Targeted Protein Degraders.
BindingDB (2022) · UC San Diego · doi:10.7270/q2mc93n5
BindingDB Entry 50010808: Medicinal Chemistry of Inhibiting RING-Type E3 Ubiquitin Ligases.
BindingDB (2021) · UC San Diego · doi:10.7270/q2qn6bbk
BindingDB (2025) · UC San Diego · doi:10.7270/q2b85dsn
BindingDB (2024) · UC San Diego · doi:10.7270/q22r3x4x
BindingDB Entry 50018681: A comprehensive review of BET-targeting PROTACs for cancer therapy.
BindingDB (2024) · UC San Diego · doi:10.7270/q2930zdd
BindingDB Entry 50002775: Inducing protein-protein interactions with molecular glues.
BindingDB (2020) · UC San Diego · doi:10.7270/q21g0px4
BindingDB (2024) · UC San Diego · doi:10.7270/q2vq374f
BindingDB (2024) · UC San Diego · doi:10.7270/q2pv6qt5
Modulation of pre-mRNA splicing by small molecules
Arecco, N., & Valcárcel, J. (2026) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2026.103423
Tang, J., Cheng, Z., Xie, T., Zhuang, Y., Hu, H., Li, C., Wang, H., Feng, C., & Tu, C. (2026) · Biomarker Research · doi:10.1186/s40364-026-01032-9
Aliberti, M., Chini, M. G., Bifulco, G., & Lauro, G. (2026) · ChemBioChem · doi:10.1002/cbic.70589
Beyond CRBN and VHL: DCAF16-Recruiting Degraders from Rational Design to Clinical Translation
Ge, X., Xiang, H., & Luo, G. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c02348
Zhang, X., Piao, Y., Zhang, J., Jin, Y., & Quan, H. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1992838
Metadata
- Authors
- Han, T., Goralski, M., Gaskill, N., Capota, E., Kim, J., Ting, T. C., Xie, Y., Williams, N. S., & Nijhawan, D.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Harold C. Simmons Comprehensive Cancer Center (US)
- Corresponding author
- Goralski, Maria
- Gaskill, Nicholas
- Nijhawan, Deepak
- ORCID
- Venue
- Science
- Published
- 2017-04-28
- Volume
- 356
- Issue
- 6336
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2596064219
- Cited by
- 762
- References
- 55
- Citations by year
- 2026: 72 · 2025: 86 · 2024: 122 · 2023: 99 · 2022: 86 · 2021: 99 · 2020: 86 · 2019: 56 · 2018: 40 · 2017: 15
- FWCI
- 22.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Welch Foundation (I-1879)
- Damon Runyon Cancer Research Foundation (CI-68-13)
- Cancer Prevention and Research Institute of Texas (RP150596)
- Life Sciences Research Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- indisulam, sulfonamides, RBM39, DCAF15, pre-mRNA splicing, splicing inhibition, proteasomal degradation, polyubiquitination, anticancer agents, drug resistance, biomarkers
- MeSH terms
- Animals, Antineoplastic Agents, Humans, Mutation, Neoplasms, Nuclear Proteins, RNA Splicing, Sulfonamides, RNA-Binding Proteins, Mice, Knockout, Drug Resistance, Neoplasm, Amino Acid Substitution, Xenograft Model Antitumor Assays, Ubiquitin-Protein Ligase Complexes, Cell Line, Tumor, Proteasome Endopeptidase Complex, Mice, Biomarkers, Pharmacological, Ubiquitination, Molecular Targeted Therapy, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.